期刊文献+

肝癌病人营养不良的特点与营养支持 被引量:2

Malnourished characteristics in hepatocellular carcinoma patients and nutritional support
原文传递
导出
出处 《中国实用外科杂志》 CSCD 北大核心 2002年第11期649-650,共2页 Chinese Journal of Practical Surgery
  • 相关文献

参考文献6

  • 1[1]Fan ST. Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy. Hepatogastroenterology, 2002,49(43):17
  • 2[2]Merli M, Riggio O, Servi R, et al. Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma. Nutrition,1992,8(5):321
  • 3[3]Fan ST, Lo CM, Lai ECS, et al. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Eng J Med, 1994,331(23):1547
  • 4[4]ASPEN Board of Directors and The Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN, 2002,26(1):1SA
  • 5[5]The San-in Group of Liver Surgery. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. Br J Surg, 1997,84(11):1525
  • 6[6]Hanazaki K, Kajikawa S, Fujimori Y, et al. Effects of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular carcinoma. Hepatogastroenterology, 2000, 47(32):461

同被引文献26

  • 1Dhaliwal R, Jurewitsch B, Harrietha D, et al. Combination enteral and parenteral nutrition in critically ill patients:harmful or benefi- cial? A systematic review of the evidence [ J ]. Intensive Care Med,2004,30(8):1666 -1671.
  • 2索博特卡主编,蔡威译.临床营养基础[M].4版.上海:上海交通大学出版社,2013:442.
  • 3Char M. Branched-Chain Amino Acid Enriched Supplements as Therapy for Liver Disease [ J ]. The Journal of Nutrition,2006,136 :S295 - S298.
  • 4Couch M, Lai V, Cannon T, et al. Cancer cachexia syndrome inhead and neck cancer patient: part I. Diagnosis, impact on qualityof life and survival, and treatment. Head Neck. 2007;29(4):401-411.
  • 5Santarpia L, Contaldo F, Pasanisi F. Nutritional screening and earlytreatment of malnutrition in cancer patients. J Cachexia SarcopeniaMuscle. 2011;2(1):27-35.
  • 6Gullett NP, Mazurak VC, Hebbar G, et a1. Nutritional interventionsfor cancer-induced cachexia. Curr Probl Cancer. 2011;35(2):58-90.
  • 7Vander Heiden MG, Cantley LC, Thompson CB. Understandingthe Warburg effect:the metabolic requirements of cell proliferation.Science. 2009;324(5930):1029-1033.
  • 8Jayaprasad N, Anees T, Bijin T, et al. Severe hypoglycemia due topoorly differentiated hepatocellular carcinoma. J Assoc PhysiciansIndia. 2006;54:413-415.
  • 9Batista ML Jr, Peres SB, McDonald ME, et a1. Adipose tissueinflammation and cancer cachexia: possible role of nucleartranscriptionon factors. Cytokine. 2012;57(1):9-16.
  • 10Roskams T, Kojiro M. Pathology of early hepatocellularcarcinoma:conventional and molecular diagnosis. Semin Liver Dis.2010;30(1):17-25.

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部